Loading...
XTAE
EFNC-M
Market cap2mUSD
Aug 15, Last price  
261.30ILS
Name

Erech Finance Cahalacha Ltd

Chart & Performance

D1W1MN
XTAE:EFNC-M chart
P/E
P/S
23.51
EPS
Div Yield, %
Shrs. gr., 5y
15.94%
Rev. gr., 5y
-50.83%
Revenues
282k
-97.35%
121,000571,000195,00083,00040,0009,808,0006,592,00010,070,00013,390,00010,649,000282,000
Net income
-25m
L+1.01%
-28,276,000-47,339,000-15,766,000-8,947,000-7,014,000-10,300,000-6,779,0001,345,0001,024,000-25,040,000-25,293,000
CFO
-2m
L-53.88%
-22,227,000-40,309,000-20,561,000-9,994,000-7,681,000-330,000532,000-6,791,000-8,952,000-4,716,000-2,175,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Erech Finance Cahalacha Ltd, together with its subsidiaries, provides loans and credit services to small and medium sized enterprises, associations, and individual borrowers in Israel. It operates through Non-Bank Credit and Biomed Drug segments. The company is also involved in the development of drugs in the areas of diabetes and cancer. Erech Finance Cahalacha Ltd is based in Jerusalem, Israel.
IPO date
Aug 04, 2010
Employees
Domiciled in
IL
Incorporated in
IL

Valuation

Title
ILS in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT